000 01568 a2200457 4500
005 20250512200601.0
264 0 _c19860131
008 198601s 0 0 eng d
022 _a0039-128X
024 7 _a10.1016/s0039-128x(84)80033-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOttow, E
245 0 0 _aSynthesis of ent-17-(prop-1-ynyl-17 beta-hydroxy-11 beta-(4-(N,N-dimethylamino)-phenyl)-4,9-estradien-3-one, the antipode of RU-38 486.
_h[electronic resource]
260 _bSteroids
_cDec 1984
300 _a519-30 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAbortifacient Agents
_xchemical synthesis
650 0 4 _aAbortifacient Agents, Steroidal
_xchemical synthesis
650 0 4 _aAnimals
650 0 4 _aBlastocyst
_xdrug effects
650 0 4 _aEstrenes
650 0 4 _aFemale
650 0 4 _aGlucocorticoids
_xantagonists & inhibitors
650 0 4 _aIndicators and Reagents
650 0 4 _aLiver Neoplasms, Experimental
_xenzymology
650 0 4 _aMagnetic Resonance Spectroscopy
650 0 4 _aMifepristone
650 0 4 _aOptical Rotation
650 0 4 _aRats
650 0 4 _aRats, Inbred Strains
650 0 4 _aStereoisomerism
650 0 4 _aStructure-Activity Relationship
650 0 4 _aTyrosine Transaminase
_xmetabolism
700 1 _aBeier, S
700 1 _aElger, W
700 1 _aHenderson, D A
700 1 _aNeef, G
700 1 _aWiechert, R
773 0 _tSteroids
_gvol. 44
_gno. 6
_gp. 519-30
856 4 0 _uhttps://doi.org/10.1016/s0039-128x(84)80033-1
_zAvailable from publisher's website
999 _c6152822
_d6152822